Literature DB >> 31367988

Putting the Hindgut Hypothesis to the Test in a Diabetic Zucker Rat Model.

Claudia Laessle1, Ke Jin2, Gabriel J Seifert2, Sylvia Timme-Bronsert3, Stefan Fichtner-Feigl2, Goran Marjanovic2, Jodok Matthias Fink2.   

Abstract

BACKGROUND: The hindgut theory hypothesizes a key role of differential hindgut stimulation following metabolic procedures in ameliorating diabetes mellitus. We used two strategies to remove the hindgut from intestinal continuity in order to analyze its impact on diabetes mellitus.
METHODS: Loop duodeno-jejunostomy (DJOS) with exclusion of one-third of total intestinal length was performed in 3 groups of 9-week-old Zucker diabetic fatty rats. In group 1, no further alteration of the intestinal tract was made. Group 2 received additional ileal exclusion (IE). Group 3 underwent additional resection of 50% of the ileum with side-to-side ileocecal anastomosis (IR). One, 2, and 4 months after surgery, fasting blood glucose levels, oral glucose tolerance tests (OGTT), and glucose-stimulated hormone analyses were conducted, and bile acid blood levels were compared. Body weight was documented weekly.
RESULTS: In relation to DJOS, glucose control was not impaired in IR or IE. On the contrary, only IR could maintain preOP glucose values until 4 months. There were no significant weight differences between the groups. Confirming effective ileal diversion, bile acid blood levels were significantly higher in the DJOS group compared with both IR and IE (p = 0.0025 and p = 0.0047). Operative interventions had no impact on GLP-1 levels at any time point (ANOVA p > 0.05 for all). Insulin secretion was preserved in all groups.
CONCLUSION: This data supports the hypothesis that the mechanisms driving amelioration of diabetes mellitus are complex and cannot be reduced to the ileum.

Entities:  

Keywords:  Diabetes; Duodeno-jejunal bypass; Metabolic surgery; Zucker rat

Mesh:

Substances:

Year:  2019        PMID: 31367988     DOI: 10.1007/s11695-019-04079-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  32 in total

1.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

2.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.

Authors:  M Shimabukuro; Y T Zhou; M Levi; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Common Channel Length in Bypass Surgery Does Not Impact T2DM in Diabetic Zucker Rats.

Authors:  Claudia Laessle; Sven Michelmichel; Goran Marjanovic; Simon Kuesters; Gabriel Seifert; Ulrich T Hopt; Jodok Matthias Fink
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

4.  Systematic ileal transposition in Zucker rats shows advantage for long segment distal transposition.

Authors:  Jodok Matthias Grueneberger; Iwona Karcz-Socha; Tomek Sawczyn; Judith Kosmowski; Dominica Stygar; Matthias Goos; Simon Küsters; Krystyna Zwirska-Korczala; Goran Marjanovic; Tobias Keck; Ulrich Theodor Hopt; W Konrad Karcz
Journal:  Surgery       Date:  2013-09-03       Impact factor: 3.982

5.  Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.

Authors:  Yuan Liu; Yong Zhou; Yong Wang; Donghua Geng; Jingang Liu
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

6.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

8.  Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.

Authors:  Jill S Carmody; Rodrigo Muñoz; Huali Yin; Lee M Kaplan
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-29       Impact factor: 4.310

9.  Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes.

Authors:  Hirofumi Imoto; Chikashi Shibata; Fumie Ikezawa; Daisuke Kikuchi; Soutoku Someya; Koh Miura; Takeshi Naitoh; Michiaki Unno
Journal:  Surg Today       Date:  2013-06-20       Impact factor: 2.549

Review 10.  Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?

Authors:  Chloé Amouyal; Fabrizio Andreelli
Journal:  J Diabetes Res       Date:  2016-06-12       Impact factor: 4.011

View more
  2 in total

1.  Reverse Transposition - a New Surgical Model for the Study the Role of Ileum in Glucose Metabolism.

Authors:  L V Sevastyanov; E M Turgunov; D V Shestakov
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

2.  Improvement of Diabetes Mellitus After Colorectal Cancer Surgery: A Retrospective Study of Predictive Factors For Type 2 Diabetes Mellitus Remission and Overall Survival.

Authors:  Dong Peng; Xiao-Yu Liu; Yu-Xi Cheng; Wei Tao; Yong Cheng
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.